We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Shortages and supply disruptions (17)
- Safety monitoring and information (121)
- Compliance and enforcement (32)
- Import and export (28)
- Sunscreens (7)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
490 result(s) found, displaying 451 to 475
-
Safety alerts
-
-
Safety alertsGinkgo biloba products with high quercetin and rutin levels have been identified. Quality standards are being reviewed.
-
Safety alertsPanvax H1N1 influenza vaccine has been approved for use in adults and children over 10 years old, with additional data needed for younger children.
-
Safety alertsAdvise to exercise caution when using Australian Hydroxycut products
-
Market actionsChuan Xiong Cha Tiao Wan pills have been recalled due to the presence of aristolochic acids, which can cause severe kidney damage and urinary tract cancer. Stop using them immediately and consult your doctor for advice.
-
Market actions
-
Market actions
-
Safety alerts
-
Market actionsClexane (enoxaparin) is being recalled due to contamination concerns, and patients should check with their doctor or pharmacist to see if their supply is affected.
-
Market actionsConsumers should stop using Clexane (enoxaparin) from the newly recalled batch due to impurity concerns. Check with your doctor or pharmacist to see if your supply is affected and return any contaminated product. If you have any concerns, consult your doctor.
-
-
Market actionsCertain batches of Clexane (enoxaparin) have been recalled because of an impurity. Stop using it, check with your healthcare provider, and return any affected product. If you have concerns, consult your doctor.
-
Safety alerts
-
Market actionsContinuing Australian reporting of bizarre and sometimes dangerous sleep related behaviours such as sleep walking and sleep driving in some users of zolpidem.
-
Market actions
-
Safety alertsPhenylpropanolamine is no longer available in Australia due to safety concerns, including the risk of haemorrhagic stroke. Consult your doctor if you have concerns.
-
Safety alertsParoxetine use in early pregnancy may increase the risk of congenital malformations, particularly heart defects, so women planning to become pregnant or in early pregnancy should consult their doctor.
-
Safety alertsSafety review of SSRI antidepressants for pregnant women due to possible infant heart defects.
-
Safety alertsSafety review of SSRI antidepressants for pregnant women due to potential heart defects in infants, especially with paroxetine.
-
Safety alertsSome Ayurvedic medicines have been found to contain toxic heavy metals. We're working on improving quality standards.
-
Safety alertsWe are advising that some polio vaccines produced between 1957 and 1963 were contaminated with SV40, a simian virus.
-
Safety alertsSSRI antidepressants under review for use in young people due to safety issues.
-
Safety alertsWe are advising that products containing Greater Celandine (Chelidonium majus) may cause liver problems. Use under healthcare supervision and consult your doctor if you have concerns.
-
Safety alertsFact sheet to inform consumers about the safe use of paracetamol